MET Stock — Price, Charts & Analysis

MetLife, Inc. (MET) has a trailing P/E of 18.08x and a forward P/E of 8.66x. This places MET in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

MET trades with 18.08x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MET looks overvalued or undervalued.

MET's P/E of 18.08x should be judged against Financial Services peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

MET's trailing EPS is $5.22 and forward EPS is $10.90. Reported earnings growth is 5.80%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit MetLife, Inc. generated for each share. MET's trailing EPS is $5.22, and investors usually prefer EPS that is positive and growing over time.

MetLife, Inc. has a market cap of $59.96B, making MET a large-cap stock based on the current market value shown on Worldtickers.

MET's latest stock price on Worldtickers is $94.36. The latest move is $0.90 or 0.96%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

MET's quote includes a latest price of $94.36. The market open is $94.20. Previous close is $93.46. The intraday range is $94.02 to $94.91.

MET is up in the latest quote, with a move of $0.90 or 0.96%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

MET generated $79.40B in trailing revenue. Revenue growth is 10.50%, which helps show whether demand is expanding or slowing.

MET's revenue growth is 10.50%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, MET shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is $3.44B.

Gross margin is 23.95%. Margins show how efficiently MetLife, Inc. turns revenue into profit.

MetLife, Inc. carries $50.31B and holds $27.32B in cash.

MET holds $27.32B on its balance sheet.

MET's book value per share is $43.03.

Yes, MetLife, Inc. pays a dividend of $2.37 per share annually. The dividend yield is 254.00%. The payout ratio is 43.97%.

MET's dividend yield is 254.00%. Its payout ratio is 43.97%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for MET. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through MetLife, Inc.'s investor relations materials.

MET's five-year average dividend yield is 293.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 78.61% of MET shares. Insiders hold 16.35% of shares. Ownership mix helps investors understand how much of MetLife, Inc. is held by professional investors and company insiders.

MET has 635.48M shares outstanding. Float shares are 531.32M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for MET, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for MET is $10.90. Earnings growth is 5.80%. Revenue growth is 10.50%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

MET's trailing EPS is $5.22. Forward EPS is $10.90. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

MET is in the Financial Services sector. Its earnings multiple is 18.08x. Its latest displayed growth metric is 10.50%. Compare these figures with sector peers before deciding whether MetLife, Inc. is stronger or weaker than average.

MET trades at $94.36. The stock trades at 18.08x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of MetLife, Inc.'s fundamentals.

MET risks include company execution, valuation, competition in Financial Services, interest rates, and broad market volatility. Beta is 0.76, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

MET should be compared with companies in Insurance - Life. Its earnings multiple is 18.08x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

MetLife, Inc. (MET) operates in Financial Services, specifically Insurance - Life. MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid

MET trades on NYSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

MET stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

MetLife, Inc.'s official website listed on Worldtickers is investor.metlife.com/phoenix.zhtml?c=121171&p=irol-irhome. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

MetLife, Inc. employs about 46K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

MetLife, Inc. is headquartered in New York, NY, United States. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

MET is in the Financial Services sector and the Insurance - Life industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

MET has traded between $67.33 and $100.93 over the past 52 weeks. At $94.36, it is 6.51% below the high and 40.15% above the low. The 52-week range helps gauge long-term price momentum.

MET is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $92.00 and its 200-day moving average is $80.03.

MET's RSI is 48.42. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

MET's latest RSI reading is 48.42, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for MET is near $90.78. Key resistance is near $100.93. Breaks above resistance or below support can change the short-term technical setup.

MET's nearest reported support level is $90.78. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

MET's nearest reported resistance level is $100.93. A breakout above resistance can improve momentum, especially when volume confirms the move.

MET trades about 3.77M shares daily on average. The latest displayed volume is 1.43M shares. Volume helps show liquidity and whether trading interest is unusually high or low.

MET's MACD is -0.70, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

MET is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 48.42 (neutral). MACD is bearish. Nearest support is around $90.78. Resistance is around $100.93. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $96.39 (-2.10% from price). MA50 is $92.00 (2.56% from price). MA200 is $80.03 (17.91% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MET's MA20 is $96.39. MA50 is $92.00. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

MET's pivot is near $94.15. Support is near $90.78. Resistance is near $100.93. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for MET is near $91.70. The next upper resistance zone is near $97.20. These levels help define risk and possible follow-through zones after a breakout or breakdown.

MET's Bollinger range is roughly $93.66 to $99.12. Band width is near 5.66%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

MET's ATR-based typical daily range is about 1.89%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 1.43M shares. Average volume is about 3.77M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

MET's all-time high shown on Worldtickers is $100.93. Its all-time low is $10.13. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

MET has a beta of 0.76, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.